Cytokinetics Inc., of South San Francisco, presented results of a trial testing CK-2127107 in healthy male volunteers at the International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders in Kobe, Japan. The compound activates the fast skeletal muscle troponin complex.